Enzolution® CD38 Assay System
The Enzolution CD38 Assay System is a comprehensive assay technology to assess the activity of CD38, a cancer and inflammatory-related disease target.
  • Includes enzyme, substrate, plates, and buffers
  • For use with the Transcreener ADPR Assay (Sold Separately)
  • Easy-to-use and HTS-ready
  • Ultra-sensitive detection – Use less enzyme!

Is your plate reader compatible?    Find out now!

SKU: N/A Category:

Interrogating CD38 & PARG with Transcreener’s ADPR Assay

This field is for validation purposes and should be left unchanged.
Name(Required)
Download Icon

CD38 Assay Services

Interested in moving your program forward with BellBrook’s CD38 Assay services? BellBrook scientists will use their extensive biochemistry and enzymology expertise to work with you and accelerate your CD38 discovery program.

Lead Discovery Services Include:

  • Inhibitor Screening – To identify or confirm activity with the target.
  • Inhibitor Potency Profiling – Dose-response with target and/or related proteins. Fast IC50 results.
  • Mechanism of Action Studies – Kinetic analysis to define the mode of inhibition.
Scientist pipetting into a microplate beside a microscope.

Contact Us About CD38 Assay Services

Please fill out the form below. We will respond quickly to get the conversation moving and learn how we can help. We keep things discrete, confidential, and professional.

Name(Required)

Interconnections Between the DNA Damage Response and Innate Immunity

There is extensive crosstalk between the DNA damage response (DDR) pathways and innate immune pathways. Both the individual pathways and the interconnections between them are a focus for exciting new small molecule drug therapeutics that target cancers and debilitating autoimmune disorders. The Transcreener HTS Assay platform accelerates these efforts by providing a robust and easy-to-use biochemical assay to measure activity of key enzymes in the innate immune and DDR pathway.

In this guide, we provide an overview of the DDR and innate immune pathway, and describe Transcreener Assays and Assay Systems for key therapeutic targets. The enzyme targets discussed include:

DDR

  • POLQ
  • WRN
  • PARP1
  • PARG
  • DNA PK

Innate Immunity

  • cGAS
  • TREX1
  • TBK1
  • IKKβ
  • IRAK4
  • ENPP1
  • CD38
  • OAS-1
  • RIG-1/MDA5
  • DDX3
  • CD39
  • CD73
DNA Damage Response and Innate Immunity Preview

This field is for validation purposes and should be left unchanged.
Name(Required)

Resources

Find the right resources to help you get to your solution faster.

Questions? Contact Us!

Please fill out the form below. We will respond quickly to get the conversation moving and learn how we can help. We keep things discrete, confidential, and professional.

This field is for validation purposes and should be left unchanged.
Name(Required)